The effect of XXXX and @entity2165 on plasma high density lipoprotein levels in @entity1 .

@entity1 @entity1674 @entity1406 @entity2165 @entity165
1. The effects of two beta-adrenoreceptor blocking drugs, @entity1406 and @entity2165 , on plasma lipoproteins were studied in thirty-four @entity1 using a single-blind cross-over design, with a 10-day placebo washout period between drugs. 2. Compared with placebo values, neither @entity1406 nor @entity2165 influenced total plasma @entity165 levels, while total plasma @entity1674 increased slightly. 3. Low density lipoprotein protein level remained unaltered, while high density lipoprotein (HDL) @entity165 and protein were significantly reduced by both beta-adrenoreceptor blockers. 4. The ratio of total @entity165 to HDL @entity165 was increased by both drugs. 5. The data suggest that @entity1 taking these drugs over many years may be exposing themselves to increased vascular risk, despite other anticipated benefits from such therapy.
